Volume | 54 |
|
|||||
News | - | ||||||
Day High | 6.41 | Low High |
|||||
Day Low | 6.41 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Helius Medical Technologies Inc | HSDT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
6.41 | 6.41 | 6.41 | 6.61 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
5 | 54 | - | 5.69 - 20.95 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
09:34:40 | 5 | $ 6.70 | USD |
Helius Medical Technologies Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
4.68M | 708.25k | - | 787k | -14.07M | -19.87 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Helius Medical Technolog... News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HSDT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 6.50 | 7.00 | 6.01 | 6.45 | 7,291 | -0.09 | -1.38% |
1 Month | 7.55 | 7.88 | 6.01 | 6.66 | 6,191 | -1.14 | -15.1% |
3 Months | 8.82 | 10.99 | 6.01 | 8.05 | 24,946 | -2.41 | -27.32% |
6 Months | 7.75 | 14.44 | 5.69 | 9.19 | 471,787 | -1.34 | -17.29% |
1 Year | 15.00 | 20.95 | 5.69 | 11.78 | 482,338 | -8.59 | -57.27% |
3 Years | 789.60 | 1,700.00 | 5.69 | 70.48 | 683,796 | -783.19 | -99.19% |
5 Years | 15,505.00 | 18,672.50 | 5.69 | 520.13 | 551,688 | -15,498.59 | -99.96% |
Helius Medical Technolog... Description
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. The company derives its revenue from Product Sales, fees and; license sources. |